Pheophorbide a is a specific probe for ABCG2 function and inhibition

被引:301
作者
Robey, RW
Steadman, K
Polgar, O
Morisaki, K
Blayney, M
Mistry, P
Bates, SE
机构
[1] NCI, Canc Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] Xenova Res, Slough, Berks, England
关键词
D O I
10.1158/0008-5472.CAN-03-3298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pheophorbide a (PhA), a chlorophyll catabolite, was shown to be an ABCG2 substrate based on Abcg2(-/-) knockout mouse studies (J. W. Jonker et al., Proc. Natl. Acad. Sci. USA, 99: 15649-15654, 2002). We developed a functional assay for ABCG2 using PhA and the ABCG2 inhibitor fumitremorgin C. In selected cell lines expressing high levels of P-glycoprotein, multidrug resistance-associated protein 1, or ABCG2, PhA transport was observed only in cells expressing ABCG2. Fumitremorgin C-inhibitable PhA transport was found to correlate with cell surface ABCG2 expression as measured by the anti-ABCG2 antibody 5D3. We found that 100 mum of the cyclin-dependent kinase inhibitor UCN-01 or 1 mum of the P-glycoprotein inhibitor tariquidar inhibited ABCG2-mediated PhA transport. In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 lam tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01. PhA is an ABCG2-specific substrate with potential value in measuring ABCG2 function and expression in clinical samples.
引用
收藏
页码:1242 / 1246
页数:5
相关论文
共 22 条
[21]   Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity [J].
Robey, RW ;
Honjo, Y ;
Morisaki, K ;
Nadjem, TA ;
Runge, S ;
Risbood, M ;
Poruchynsky, MS ;
Bates, SE .
BRITISH JOURNAL OF CANCER, 2003, 89 (10) :1971-1978
[22]   NEW COLORIMETRIC CYTOTOXICITY ASSAY FOR ANTICANCER-DRUG SCREENING [J].
SKEHAN, P ;
STORENG, R ;
SCUDIERO, D ;
MONKS, A ;
MCMAHON, J ;
VISTICA, D ;
WARREN, JT ;
BOKESCH, H ;
KENNEY, S ;
BOYD, MR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (13) :1107-1112